CD209 and infection: Thus, results from the competition assays revealed in vitro selection of chronic stage R5 viruses, harbouring V2 PNGS aa160, in the DC-SIGN-mediated trans-infections, while end-stage R5 variants lacking V2 PNGS aa160 dominated in the direct PBMC infections.